PHREESIA INC
PHRNYSETrading Snapshot
- Day Range
- $9.95 β $10.20
- 52-Week Range
- $7.77 β $24.25
- Volume
- $1.64B
- Avg Volume
- $1.88B
- Shares Outstanding
- 61.8M
- Next Earnings
- Dec 1, 2026
Fundamentals Snapshot
- Annual Revenue
- $481M
- Last Q Revenue
- $129M
- P/E Ratio
- 58.7
- P/S Ratio
- 1.2x
- EPS (TTM)
- $0.17
- Dividend Yield
- 0.00%
- Dilution (1yr)
- +1.6%
Why Investors Own PHR
- βHigh-growth profile β revenue up +36.2% YoY with expanding US Equity exposure.
- βHealthy economics β 63% gross margin and 7% free-cash-flow margin.
- βNew products and segments could unlock additional revenue streams.
Execution delays, intensifying competition, and valuation compression if growth decelerates.
PHREESIA INC
PHRAbout PHREESIA INC
Phreesia, Inc. offers a comprehensive, cloud-based software-as-a-service (SaaS) and payment platform specifically designed for the healthcare industry in the United States and Canada. Its flagship Phreesia Platform streamlines the patient intake process and facilitates integrated patient payment processing. The platform is accessible via multiple modalities, including Phreesia Mobile (a patient-facing mobile application), Phreesia Dashboard (a web-based portal for healthcare clients), self-service tablets known as PhreesiaPads, and on-site Arrivals Kiosks. The Phreesia Platform integrates a suite of specialized modules: An automated patient self-registration system. A revenue cycle management solution providing insurance verification, point-of-sale payment applications, and cost estimation tools. Access solutions for online appointment scheduling, reminders, and referral tracking. A life sciences solution delivering targeted, clinically relevant marketing content to patients. Additionally, a clinical support solution gathers clinical intake and patient-reported outcome (PRO) data across approximately 25 specialties, and enables healthcare clients to communicate with patients via surveys, announcements, text and email messaging, and health campaigns. Dedicated COVID-19 support modules assist with vaccine delivery management, identifying vaccine-hesitant individuals, screening for risk factors, facilitating contactless check-in, and managing telehealth visit intake. Phreesia serves a diverse clientele, including individual patients; single and multi-specialty practices, along with health systems; and pharmaceutical, medical device, and biotechnology firms. Established in 2005, the company maintains its headquarters in Raleigh, North Carolina.
Otter Score Breakdown
How it's scoredFive components, each rated 1β5β and equally weighted (20%), averaged to a 0β100 score:π Quality β gross marginπ Growth β revenue YoYβοΈ Valuation β P/S ratioβ‘ Momentum β 30-day price changeπ§ Dilution β 1-yr share issuance (buybacks score higher)Analyst Price Target
βLatest News & Updates
PHREESIA INC tops quarterly estimates as demand accelerates
Revenue grew double digits with management guiding above consensus; margins continued to expand.
Analysts lift PHR price targets on improving margins
Several firms raised targets, citing stronger free cash flow and a healthier backlog.
PHREESIA INC announces new agreement to expand its footprint
The move broadens the companyβs reach and could add incremental revenue over the next year.